Available in the shop
- Semaglutide 5 mg — $84.00
- Semaglutide 10 mg — $136.50
- Semaglutide 15 mg — $147.00
- Semaglutide 20 mg — $178.50
- Semaglutide 30 mg — $220.50
- Cagrilintide 5 mg + Semaglutide 5 mg — $329.70
Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.
Identification
| Field of research | Weight research |
|---|---|
| Formula | C187H291N45O59 |
| Molecular weight | 4114 g/mol |
| CAS number | 910463-68-2 |
| Also known as | Rybelsus, Ozempic, Wegovy, NN9535, NN 9535, NNC 0113-0217, 53AXN4NNHX, NN-9535, CHEBI:167574, NNC-0113-0217 |
| PubChem | CID 56843331 |
Summary
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for weight management.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trialClinical Trial, Phase IIIRandomized Controlled TrialResearch Support, Non-U.S. Gov'tEquivalence TrialKadowaki T, Isendahl J, Khalid U et al. · Lancet Diabetes Endocrinol, 2022 · PMID 35131037 · DOI
- Safety of SemaglutideResearch Support, Non-U.S. Gov'tReviewSmits MM, Van Raalte DH · Front Endocrinol (Lausanne), 2021 · PMID 34305810 · DOI
- Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-AnalysisMeta-AnalysisSystematic ReviewTan HC, Dampil OA, Marquez MM · J ASEAN Fed Endocr Soc, 2022 · PMID 36578889 · DOI
- A systematic review of the effect of semaglutide on lean mass: insights from clinical trialsSystematic ReviewBikou A, Dermiki-Gkana F, Penteris M et al. · Expert Opin Pharmacother, 2024 · PMID 38629387 · DOI
- Semaglutide lowers body weight in rodents via distributed neural pathwaysResearch Support, Non-U.S. Gov'tGabery S, Salinas CG, Paulsen SJ et al. · JCI Insight, 2020 · PMID 32213703 · DOI
- Wegovy (semaglutide): a new weight loss drug for chronic weight managementReviewSingh G, Krauthamer M, Bjalme-Evans M · J Investig Med, 2022 · PMID 34706925 · DOI
- Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionComparative StudyObservational StudyKrüger N, Schneeweiss S, Fuse K et al. · JAMA, 2025 · PMID 40886075 · DOI
- Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trialRandomized Controlled TrialMulticenter StudyResearch Support, Non-U.S. Gov'tRyan DH, Lingvay I, Deanfield J et al. · Nat Med, 2024 · PMID 38740993 · DOI
Top 8 of 5,624 results, by relevance. See all on PubMed.
Search query "Semaglutide"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 56843331 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | Semaglutide |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.